Government will not reduce the foreign direct investment (FDI) cap in the existing pharmaceutical companies. Commerce Minister Anand Sharma told this while talking to reporters in New Delhi today.

Currently, 100 per cent FDI is permitted in brownfield pharma firms through clearance from the Foreign Investment
Promotion Board (FIPB). Over 95 per cent of FDI in the pharma sector between April 2012 and June 2013 was in brownfield or existing projects. India has received 2 billion dollar of FDI in the sector during this period.